Skip to search formSkip to main contentSkip to account menu

TAK-960

Known as: PLK1 Inhibitor TAK-960, Polo-like Kinase 1 Inhibitor TAK-960 
An orally available, Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor TAK-960 selectively… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
498 In vivo evaluation of TAK-960, a novel, orally bioavailable inhibitor of Polo-like kinase 1
2010
2010
503 In vitro characterization of TAK-960, a novel, small molecule inhibitor of Polo-like kinase 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)